Crispr Therapeutics shares owned by Syntax Research
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Syntax Research
from 13F filings
Historical chart of Syntax Research investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Syntax Research consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Syntax Research
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $14k | 250 | 54.01 |
| 2024-03-31 | $17k | 250 | 68.16 |
| 2023-12-31 | $16k | 250 | 62.60 |